EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer

Aurora Laborda-Illanes, Soukaina Boutriq iD, Lucía Aranega-Martín iD, Daniel Castellano-Castillo, Lidia Sánchez-Alcoholado, Isaac Plaza-Andrades, Jesús Peralta-Linero, Emilio Alba, José Carlos Fernández-García, Alicia González-González iD, María Isabel Queipo-Ortuño

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Aurora Laborda-Illanes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Clinical Management Unit, Virgen de la Victoria University Hospital, Málaga Biomedical Research Institute (IBIMA) BIONAND Platform-C…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Breast Neoplasms, Melatonin. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Salud de la Junta de Andalucía, Fundación Unicaja, UMA-FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence suggests a bidirectional relationship between gut microbiota, melatonin synthesis, and breast cancer (BC) development in hormone receptor-positive patients (HR+HER2+ and HR+HER2-). This study investigated alterations in gut microbiota composition, the serum serotonin–N-acetylserotonin (NAS)–melatonin axis, fecal short-chain fatty acids (SCFAs) and beta-glucuronidase (βGD) activity, and serum zonulin in HR+ BC patients compared to healthy controls. Blood and fecal samples were analyzed using mass spectrometry for serotonin, NAS, melatonin, and SCFAs; ELISA for AANAT, ASMT, 14-3-3 protein, and zonulin; fluorometric assay for βGD activity; and 16S rRNA sequencing for gut microbiota composition. HR+ BC patients exhibited gut dysbiosis with reduced Bifidobacterium longum and increased Bacteroides eggerthii, alongside elevated fecal βGD activity, SCFA levels (e.g., isovaleric acid), and serum zonulin, indicating increased intestinal permeability. Serum serotonin and N-acetylserotonin (NAS) levels were elevated, while melatonin levels were reduced, with a higher NAS/melatonin ratio in BC patients. AANAT levels were increased, and ASMT levels were decreased, suggesting disrupted melatonin synthesis. Bifidobacterium longum positively correlated with melatonin and negatively with βGD activity, while Bacteroides eggerthii showed a positive correlation with βGD activity. These findings suggested that gut microbiota alterations, disrupted melatonin synthesis, microbial metabolism, and intestinal permeability may contribute to BC pathophysiology. The NAS/melatonin ratio could represent a potential biomarker, necessitating further mechanistic studies to confirm causality and explore therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBreast NeoplasmsMelatoninHumansFemaleMiddle AgedSerotoninFecesFatty Acids, VolatileAdultHaptoglobinsProtein PrecursorsAgedDysbiosisCholera ToxinRNA, Ribosomal, 16SErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

SCFAsbeta-glucuronidase activitydysbiosisgut microbiotahormone receptor-positive breast cancermelatonergic pathwaypermeabilityserotonin-NAS-melatonin axis

Substanzen

MelatoninSerotoninFatty Acids, VolatileHaptoglobinsProtein PrecursorsCholera ToxinRNA, Ribosomal, 16SErb-b2 Receptor Tyrosine Kinaseszonulin

Autor:innen und Institutionen

  • Medical Oncology Clinical Management Unit, Virgen de la Victoria University Hospital, Málaga Biomedical Research Institute (IBIMA) BIONAND Platform-CIMES-UMA, 29010 Malaga, Spain.
  • Department of Medicine and Pediatrics, Faculty of Medicine, University of Malaga, 29071 Malaga, Spain.
  • Department of Endocrinology and Nutrition, Regional University Hospital of Malaga, Biomedical Research Institute of Malaga (IBIMA), Faculty of Medicine, University of Malaga, 29010 Malaga, Spain.
  • Department of Surgical Specialties, Biochemical and Immunology, Faculty of Medicine, University of Málaga, 29071 Malaga, Spain.

ORCID-Profile: Soukaina Boutriq, Lucía Aranega-Martín, Alicia González-González

Förderung

  • Consejería de Salud de la Junta de Andalucía
  • Fundación Unicaja
  • UMA-FEDER
  • ALIANZA MIXTA ANDALUCÍA-ROCHE
  • Instituto de Salud Carlos III
  • Universidad de Málaga
  • Ministerio de Ciencia, Innovación y Universidades
  • Ministerio de Ciencias e Innovación

Zitieren

APA

Laborda-Illanes, A., Boutriq, S., Aranega-Martín, L., Castellano-Castillo, D., Sánchez-Alcoholado, L., Plaza-Andrades, I., Peralta-Linero, J., Alba, E., Fernández-García, J. C., González-González, A., & Queipo-Ortuño, M. I. (2025). Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146801

Vancouver

Laborda-Illanes A, Boutriq S, Aranega-Martín L, Castellano-Castillo D, Sánchez-Alcoholado L, Plaza-Andrades I, et al. Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146801

BibTeX
@article{LabordaIllanes2025,
  author = {Laborda-Illanes, Aurora and Boutriq, Soukaina and Aranega-Martín, Lucía and Castellano-Castillo, Daniel and Sánchez-Alcoholado, Lidia and Plaza-Andrades, Isaac and Peralta-Linero, Jesús and Alba, Emilio and Fernández-García, José Carlos and González-González, Alicia and Queipo-Ortuño, María Isabel},
  title = {Exploring the Interplay Between Gut Microbiota and the Melatonergic Pathway in Hormone Receptor-Positive Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146801}
}
Kostenlos starten →